General MedicationsORALGeneric
CENTRAX
PRAZEPAM
Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CENTRAX is listed in Drugs@FDA under application 017415 (NDA).
Marketing status: Discontinued Active ingredient PRAZEPAM Form and strength TABLET;ORAL - 10MG Sponsor PARKE DAVIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview CENTRAX is listed in Drugs@FDA under application 017415 (NDA). Marketing status: Discontinued Active ingredient PRAZEPAM Form and strength TABLET;ORAL - 10MG Sponsor PARKE DAVIS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.